期刊档案 · IMMUNOLOGY
Indian Journal of Medical Microbiology
ISSN 0255-0857 · eISSN 1998-3646 · Wolters Kluwer Medknow Publications · INDIA · Quarterly
Indian Journal of Medical Microbiology 中科院 医学 4区（2025 年升级版），影响因子 1.5，完全开放获取，APC 约 2,210 美元，近 24 个月 108 篇文章投稿到接收中位 106 天，录用比例容易（社区反馈），2025 年发文 189 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Indian Journal of Medical Microbiology 由 Wolters Kluwer Medknow Publications 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Antibiotic Resistance in Bacteria、Bacterial Identification and Susceptibility Testing、Antifungal resistance and susceptibility 等主题的论文，这 3 个主题约占 25.2%，主导子领域为 Infectious Diseases。（根据 OpenAlex 主题统计与中科院分区数据生成）
An official journal of the Indian Association of Medical MicrobiologistsIndian Journal of Medical Microbiology (IJMM) provides comprehensive coverage of medical microbiology, as well as infectious diseases. We welcome wide ranging contributions; from basic research at laboratory to clinical trials, including bacteriology, mycobacteriology, virology, mycology and parasitology, infection prevention and control, and infectious diseases.We publish articles under the following subject categories:Antimicrobial susceptibility and antimicrobial stewardship: surveillance of antimicrobial susceptibility in bacteria, viruses, fungi and parasites of importance in humans, animals, and the environment that are frequently interconnected; mechanisms of action, resistance and interactions. The role of antimicrobial stewardship programs in hospitals and its effectiveness.Clinical microbiology: understanding pathogenesis, virulence factors of the diseases caused by bacteria, viruses, mycobacteria, parasites and fungi in humans, clinical presentation, newer methods and tools for diagnosis of disease and therapeutic options; community health with respect to infection burden and prevention, disease epidemiology and climate change.Emerging infectious diseases: understanding the epidemiology of new and emerging infections or old infections having a resurgence in humans including zoonosis; their pathophysiology, clinical presentation, diagnosis and treatment.Medical mycology and mycobacteriology: pathogenesis, diagnosis, drug susceptibility, therapy, clinical immunology, autoimmune diseases, and immune responses to infections, vaccine development, epidemiology, public health and outbreak investigation of diseases in humans.Hospital infection: various hospital associated infections -their analysis, control, prevention and lessons learnt, newer methodologies to track HAI's, hospital outbreaks.Molecular studies: application of phenotypic, genotypic and molecular techniques in the study of virulence, AMR genes, epidemiology, outbreak investigations and public health.Microbiome and microbial ecology in health: the normal microbiome and dysbiosis; structure of microbial ecosystems and communities; microbial ecology, with an emphasis on how microorganisms interact with their environment, their host and each other and their impact on general health and treatment of disease. the normal microbiome and dysbiosis and its association with disease conditions; and microbial ecosystems and communities.Immunology: Clinical immunology, autoimmune diseases, and immune responses to infectionsVaccinology and therapeutics: research in identifying vaccine targets, novel drug discovery and therapeutics.IJMM publishes article types such as original research, review articles, systematic reviews, meta-analysis, clinical trials, correspondence, case reports and a new section - infectious disease grand rounds.High quality scientific content related to infections from dental and veterinary sciences (like zoonotic illnesses) can also be submitted.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：IMMUNOLOGY
主编 Sangeeta Joshi出版商官网
编委会国家分布：未见中国大陆编委；主要国家 印度 41、美国 8、英国 7、南非 2、日本 1（共 64 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology11.3%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology7.1%
- Antifungal resistance and susceptibilityMedicine6.8%
- Mycobacterium research and diagnosisMedicine5.8%
- Tuberculosis Research and EpidemiologyMedicine5.5%
- Fungal Infections and StudiesMedicine5.4%
- Antimicrobial Resistance in StaphylococcusMedicine5.1%
- Antibiotic Use and ResistanceImmunology and Microbiology5%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 免疫学IMMUNOLOGY | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 免疫学IMMUNOLOGY | 4 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 免疫学IMMUNOLOGY | 4 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIEScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 1.5LetPub ·
- 影响因子（出版商公布）
- 1.5出版商官网 ·
- CiteScore 2026-06
- 2.2LetPub ·
- CiteScore（出版商公布）
- 2.2出版商官网 ·
- SJR 2026-06
- 0.42LetPub ·
- SNIP 2026-06
- 0.68LetPub ·
- h-index
- 41LetPub ·
- h-index
- 81OpenAlex ·
- i10-index
- 1,272OpenAlex ·
- 两年平均被引
- 1.2OpenAlex ·
- 自引率
- 0%LetPub ·
- Gold OA 文章占比
- 100%LetPub ·
发文规模
- 年文章数
- 147LetPub ·
逐年发文量 OpenAlex 统计 · 累计 4,189 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 220 | 220 | 24 |
| 2025 | 189 | 189 | 185 |
| 2024 | 186 | 186 | 506 |
| 2023 | 156 | 156 | 624 |
| 2022 | 160 | 160 | 825 |
| 2021 | 606 | 606 | 1,212 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
106 天投稿到接收中位数 · P25–P75 73 天 – 163 天
- 接收到上线
- 中位数 1 天（108 篇）
- 投稿到上线
- 中位数 108 天
- 样本
- 108 篇有投稿与接收日期的文章（窗口内共 425 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 较慢,6-12周LetPub ·
- 平均录用比例（社区反馈）
- 容易LetPub ·
- 投稿到首次决定
- 8 天出版商官网 ·
- 外审后首次决定
- 2 天出版商官网 ·
- 投稿到接收
- 142 天出版商官网 ·
- 评审方式
- 双盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取OpenAlex
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 2,210 / EUR 2,070 / GBP 1,770 / JPY 274,110 | — | — | |
| 出版商官网 | USD 2,570 | — | — |
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点5 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- ≥ 3 个
- 正文篇幅
- ≤ 2,500 词
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 投稿信（Cover letter）
- 必须提供
接收的文章类型15 种，含篇幅限制
- brief communicationManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …正文 ≤ 1,000 词
- brief communicationsBrief communications: Word limit of 1000 words. Recommended for brief observations of a study that does not warrant a full length paper.未说明篇幅
- case reportManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …正文 ≤ 1,000 词
- case reportsCase reports: Word limit of 1000 words. Recommended for description of uncommon infections.未说明篇幅
- editorialnd may not exceed 2500 words; the Guest Editorial may or may not have references and should not exceed maximum of 1000 words and 10 references. Kindly note that…正文 ≤ 1,000 词
- infectious disease grand roundsInfectious disease Grand rounds: The word limit is 1000 words.未说明篇幅
- letterManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …未说明篇幅
- letters to the editorManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …未说明篇幅
- meta-analysisManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …未说明篇幅
- original researchManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …未说明篇幅
- original research articleManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …未说明篇幅
- original research articles and multicentric studiesOriginal research articles and multicentric studies: We encourage original research articles. These articles must have text shorter than 2500 words, excluding r…未说明篇幅
- reviewManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …未说明篇幅
- systematic reviewManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …正文 ≤ 3,500 词 · 摘要 ≤ 300 词 · 参考文献 ≤ 50
- systematic reviews and meta-analysisSystematic reviews are limited to 3500 words. Word count for Meta-analysis is optional.未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、出版伦理、许可与版权、开放获取、同行评审、预印本
- AI 使用 Declaration of generative AI use
作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Authorship
遵守上述作者身份要求即符合国际医学期刊编辑委员会（ICMJE）2024年1月更新版的作者身份标准。 模型中文摘要
By adhering to the authorship requirements stated above, authors meet the International Committee of Medical Journal Editors (ICMJE) criteria [updated version January 2024] on authorship.
原文 ↗出版商官网 ·- 利益冲突 Declaration of competing interests
所有作者必须披露可能不当影响或偏倚其工作的与他人或组织的财务和个人关系。 模型中文摘要
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
原文 ↗出版商官网 ·- 出版伦理
作者必须遵守爱思唯尔出版伦理政策中规定的伦理准则。 模型中文摘要
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
原文 ↗出版商官网 ·- 许可与版权 License options
作者将获得开放获取用户许可选项，这些选项决定作者和第三方如何复用其开放获取文章。 模型中文摘要
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
原文 ↗出版商官网 ·- 开放获取 Open access
本刊引导作者查阅开放获取信息页面以了解该期刊的开放获取选项。 模型中文摘要
We refer you to our open access information page to learn about open access options for this journal.
原文 ↗出版商官网 ·- 同行评审 Peer review
本刊采用双盲匿名审稿流程，稿件通常至少由两名审稿人独立评审，最终录用或拒稿决定由编辑作出。 模型中文摘要
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
原文 ↗出版商官网 ·- 预印本 Preprints
作者可按照爱思唯尔文章共享政策分享预印本，在预印本服务器上分享预印本不会被视为先前发表。 模型中文摘要
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Wolters Kluwer Medknow Publications
- 出版国家或地区
- INDIA
- 出版语言
- English
- 出版周期
- Quarterly
- ISSN
- 0255-0857
- 电子版 ISSN
- 1998-3646
- 学会 / 主办单位
- Indian Association of Medical Microbiologists
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗出版商官网
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Indian Journal of Medical Microbiology 的常见问题
Indian Journal of Medical Microbiology 是中科院几区期刊？
2025 年升级版分区表中，Indian Journal of Medical Microbiology 为医学 4区，小类 免疫学 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Indian Journal of Medical Microbiology 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 1.5，CiteScore 为 2.2，h-index 为 81。
Indian Journal of Medical Microbiology 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）108 篇已发表文章登记的日期，投稿到接收的中位数为 106 天（四分位 73–163 天）；投稿社区反馈的平均审稿速度为6–12 周，平均录用比例反馈为“容易”。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Indian Journal of Medical Microbiology 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：≥ 3 个；正文篇幅：≤ 2,500 词；参考文献格式：顺序编码制（按引用顺序编号）；投稿信：必须提供。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Indian Journal of Medical Microbiology 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 64 位编委中，没有中国大陆学者；人数最多的国家是 印度（41 位）、美国（8 位）、英国（7 位）。统计按编委会页面列出的机构国家计，仅供参考。
Indian Journal of Medical Microbiology 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Indian Journal of Medical Microbiology 被 SCIE、Scopus 收录。
Indian Journal of Medical Microbiology 是开放获取期刊吗？版面费多少？
Indian Journal of Medical Microbiology 为完全开放获取。APC 约 2,210 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。